Ali, M, Auger, RR, Slocumb, NL, et al. (2009) Idiopathic hypersomnia: clinical features and response to treatment. Journal of Clinical Sleep Medicine, 5: 562–8.
Allen, RP, Picchietti, DL, Garcia-Borreguero, D, et al. (2014) Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria – history, rationale, description, and significance. Sleep Medicine, 15: 860–73.
American Academy of Sleep Medicine (2014) International Classification of Sleep Disorders (3rd edn). American Academy of Sleep Medicine.
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders (5th edn) (DSM-V). American Psychiatric Publishing.
Anderson, KN, Pilsworth, S, Sharples, LD, et al. (2007) Idiopathic hypersomnia: a study of 77 cases. Sleep, 30: 1274–81.
Anderson, KN, Shneerson, JM (2009) Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam. Journal of Clinical Sleep Medicine, 5: 235–9.
Aurora, RN, Zak, RS, Auerbach, SH, et al. (2010) Best practice guide for the treatment of nightmare disorder in adults. Journal of Clinical Sleep Medicine, 6: 389–401.
Baglioni, C, Battagliese, G, Feige, B, et al. (2011) Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. Journal of Affective Disorders, 135: 10–9.
Bassetti, C, Aldrich, MS (1997) Idiopathic hypersomnia. A series of 42 patients. Brain, 120: 1423–35.
Basu, A, Kundu, S, Khurana, H (2014). Olanzapine-induced restless leg syndrome: a case report and review of literature. Indian Journal of Pharmacology, 46: 450–2.
Becker, PM (2006) The biopsychosocial effects of restless legs syndrome (RLS). Neuropsychiatric Disease and Treatment, 2: 505–12.
Blom, K, Jernelöv, S, Kraepelien, M, et al. (2015) Internet treatment addressing either insomnia or depression, for patients with both diagnoses: a randomized trial. Sleep, 38: 267–77.
Borodkin, K, Dagan, Y (2010) Circadian rhythm disorders. In Foundations of Psychiatric Sleep Medicine (eds Winkelman, J, Plante, D): 186–201. Cambridge University Press.
Canessa, N, Castronovo, V, Cappa, SF, et al. (2011) Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment. American Journal of Respiratory and Critical Care Medicine, 183: 1419–26.
Chang, PP, Ford, DE, Mead, LA, et al. (1997) Insomnia in young men and subsequent depression: the Johns Hopkins Precursors Study. American Journal of Epidemiology, 146: 105–14.
Di Giacopo, R, Fasano, A, Quaranta, D, et al. (2012) Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease. Movement Disorders, 27: 559–61.
Epstein, LJ, Kristo, D, Strollo, PJ Jr, et al. (2009) Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. Journal of Clinical Sleep Medicine, 5: 263–76.
Fava, M, Schaefer, K, Huang, H, et al. (2011) A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression. Journal of Clinical Psychiatry, 72: 473–9.
Franzen, PL, Buysse, DJ (2008) Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues in Clinical Neuroscience, 10: 473–81.
Fulda, S (2011) Idiopathic REM sleep behaviour disorder as a long-term predictor of neurodegenerative disorders. EPMA Journal, 2: 451–8.
Greenberg, H, Lakticova, V, Scharf, SM (2017) Obstructive sleep apnea: clinical features, evaluation, and principles of management. In Principles and Practice of Sleep Medicine (6th edn) (eds Kryger, MH, Roth, T, Dement, WC): 1110–24. Elsevier.
Haba-Rubio, J (2005) Psychiatric aspects of organic sleep disorders. Dialogues in Clinical Neuroscience, 7: 335–46.
Harris, M, Glozier, N, Ratnavadivel, R, et al. (2009) Obstructive sleep apnea and depression. Sleep Medicine Reviews, 13: 437–44.
Johnson, EO, Roth, T, Breslau, N (2006) The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. Journal of Psychiatric Research, 40: 700–8.
Katz, D, McHorney, C (2002) The relationship between insomnia and health-related quality of life in patients with chronic illness. Journal of Family Practice, 51: 229–35.
Kripke, DF, Rex, KM, Ancoli-Israel, S, et al. (2008) Delayed sleep phase cases and controls. Journal of Circadian Rhythms, 6: 1–14.
Littner, M, Kushida, CA, Anderson, WM, et al. (2003) Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Sleep, 26: 337–41.
Manber, R, Chambers, AS (2009) Insomnia and depression: a multifaceted interplay. Current Psychiatry Reports, 11: 437–42.
Markov, D, Jaffe, F, Doghramji, K (2006) Update on parasomnias: a review for psychiatric practice. Psychiatry, 3: 69–76.
McGrane, IR, Leung, JG, St Louis, EK, et al. (2015) Melatonin therapy for REM sleep behavior disorder: a critical review of evidence. Sleep Medicine, 16: 19–26.
Moller, HJ, Lam, S (2008) Quality of life in excessive daytime sleepiness and hypersomnia. In Sleep and Quality of Life in Clinical Medicine (eds Verster, JC, Pandi-Perumal, SR, Streiner, DL): 107–18. Humana Press.
Montplaisir, J, Boucher, S, Nicolas, A, et al. (1998) Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome. Movement Disorders, 13: 324–9.
Moore, TJ, Glenmullen, J, Mattison, DR (2014) Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Internal Medicine, 174: 1930–3.
Morgenthaler, TI, Lee-Chiong, T, Alessi, C, et al. (2007) Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. Sleep, 30: 1445–59.
Myers, E, Startup, H, Freeman, D (2011) Cognitive behavioural treatment of insomnia in individuals with persistent persecutory delusions: a pilot trial. Journal of Behavior Therapy and Experimental Psychiatry, 42: 330–6.
Ohayon, MM, Guilleminault, C, Priest, RG (1999) Night terrors, sleepwalking, and confusional arousals in the general population: their frequency and relationship to other sleep and mental disorders. Journal of Clinical Psychiatry, 60: 268–76.
Okuji, Y, Matsuura, M, Kawasaki, N, et al. (2002) Prevalence of insomnia in various psychiatric diagnostic categories. Psychiatry and Clinical Neurosciences, 56: 239–40.
Pollack, M, Kinrys, G, Krystal, A, et al. (2008) Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Archives of General Psychiatry, 65: 551–62.
Postuma, RB, Gagnon, JF, Tuineaig, M, et al. (2013) Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal? Sleep, 36: 1579–85.
Riemann, D, Perlis, ML (2009) The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Medicine Reviews, 13: 205–14.
Roth, T (2007) Insomnia: definition, prevalence, etiology, and consequences. Journal of Clinical Sleep Medicine, 3(Suppl 5): 3–6.
Rottach, KG, Schaner, BM, Kirch, MH, et al. (2008) Restless legs syndrome as side effect of second generation antidepressants. Journal of Psychiatric Research, 42, 70–5.
Taylor, DJ, Pruiksma, KE (2014) Cognitive and behavioural therapy for insomnia (CBT-I) in psychiatric populations: a systematic review. International Review of Psychiatry, 26: 205–13.
Tek, C, Palmese, LB, Krystal, AD, et al. (2014) The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial. Schizophrenia Research, 160: 180–5.
Wirz-Justice, A (2008) Diurnal variation of depressive symptoms. Dialogues in Clinical Neuroscience, 10: 337–43.
Wulff, K, Gatti, S, Wettstein, JG, et al. (2010) Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nature Reviews Neuroscience, 11: 589–99.